Published in Hepatitis Weekly, June 19th, 2006
"HBcAg is a potent immunogen in animal models and humans and has been used as a carrier for several antigens; however, the mucosal immunogenicity of HBcAg has been poorly studied. In this study, we explored the immunogenicity and the immunoenhancing effect elicited by two different variants of the recombinant complete nucleocapside of HBV in mice by intranasal route," wrote Y. Lobaina and colleagues, Center of Genetics Engineering & Biotechnology.
They explained, "For this purpose, we...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly